Figure S5.

De novo TRM generation upon secondary vaccination in previously unperturbed sites. (A and B) Mice received GFP+ OT-I T cells (A) or barcode-labeled OT-I T cells (B) and were subjected to DNA vaccination on the right hind leg, whereas the other hind leg remained unperturbed. (A) Analysis of TRM frequencies in vaccinated (right leg) and nonvaccinated (left leg) skin sites >60 d after vaccination. (B) More than 60 d after primary vaccination, the nonvaccinated (left leg) skin site was subjected to DNA vaccination. More than 60 d after secondary vaccination, the primary and secondary vaccinated skin sites were harvested, and GFP+ TRM at the two sites were quantified. Number of barcode-labeled TRM detected at the primary and secondary skin vaccination site of nine mice. *, P < 0.05, Wilcoxon signed-rank test. Dots represent individual mice.

or Create an Account

Close Modal
Close Modal